October 5, 2007 — IntraOp Medical Corp. a provider of technology solutions for the treatment and eradication of cancer, recently announced the introduction of the Optimal Boost approach to breast cancer treatment administered by its flagship product, Mobetron.

Mobetron is a fully-portable, self-shielding electron-beam linear accelerator that delivers radiation therapy in the operating room at the time of cancer surgery. It administers intraoperative electron-beam radiation therapy (IOERT) directly to the tumor bed once a cancerous growth has been excised during surgery. The Optimal Boost method, or as it is commonly referred to in breast cancer treatment, the Bio-Boost method, consists of applying a high dosage of radiation to the tumor bed at the time of lumpectomy followed by traditional post-operative radiation therapy.

Because it does not have to pass through healthy skin, organs and tissue, IOERT can reportedly be delivered at higher and better cancer-killing doses. Guided by the radiation oncologist's clear view of the site as well as intraoperative ultrasound, IOERT also allows the electron beam to be more accurately targeted In addition, IOERT eliminates the traditional delay of external radiation therapy, which must be scheduled only after the surgery patient has healed. This can give cancer cells a chance to reconstitute and spread.

For more information: www.intraopmedical.com

Related Content

News | Proton Therapy

June 24, 2021 — Mevion Medical Systems announced that the first proton center in the Mountain West, the Senator Orrin G ...

Time June 24, 2021
arrow
News | Linear Accelerators

June 18, 2021 — Elekta announced that its Elekta Harmony radiation therapy system recently received U.S. FDA 510(k) ...

Time June 18, 2021
arrow
News | Linear Accelerators

January 20, 2021 — A joint team of researchers from Radiation Oncology at Dartmouth's and Dartmouth-Hitchcock's Norris ...

Time January 20, 2021
arrow
News | Linear Accelerators

January 4, 2021 — RAD Technology Medical Systems (RAD) announced it is expanding its portfolio of patented modular ...

Time January 04, 2021
arrow
News | Radiation Oncology

April 17, 2020 — PTW has installed the first Beamscan MR motorized 3-D water phantom in North America at the Princess ...

Time April 17, 2020
arrow
News | Radiation Oncology

January 30, 2020 — Elekta announced that it signed a contract with the Institut Jules Bordet, Brussels, for an Elekta ...

Time January 30, 2020
arrow
Technology | Quality Assurance (QA)

IBA Dosimetry GmbH announced the launch of the new enhanced myQA Machines 2019 software environment at the upcoming American Society for Radiation Oncology (ASTRO) congress, Sept. 15-19 in Chicago.

Time September 12, 2019
arrow
Videos

Kristin Higgins, M.D., medical director of radiation oncology at the Emory Clinic at the Winship Cancer Institute, and ...

Time October 29, 2018
arrow
News | Radiation Therapy

Gustave Roussy has awarded Elekta with an order for four Versa HD linear accelerators, replacing their existing installed base of competing systems. The premier European comprehensive cancer center started its radiotherapy program in 2013.

Time September 04, 2015
arrow
News

The ECRI Institute released a new techIQ brief on key factors to consider when purchasing a linear accelerator (linac) for external beam radiation therapy. The report is a compilation of results from a survey of hundreds of users of linac-based radiosurgery systems; participants were asked to rate the functions and features of the four major linac vendors: Accuray, Brainlab, Elekta and Varian Medical Systems.

Time June 23, 2015
arrow
Subscribe Now